Martin J. Crisp

Partner

crisp-martin-j
  • JD, cum laude, University of Pennsylvania Law School, 2004; James Wilson Scholar, Finalist in 2003-2004 Edwin R. Keedy Moot Court Competition, Lead Attorney in 2003-2004 Penn Law National Trial Team
  • BS, Cornell University, 2001

Qualifications

  • New York, 2005

Court Admissions

  • U.S. District Court for the Southern District of New York, 2006
  • U.S. District Court for the Eastern District of New York, 2011
  • U.S. District Court for the Northern District of New York, 2011
  • New York Super Lawyers – Rising Stars (2014-2015)
  • New York State Bar Association – Empire State Counsel (2014)

Martin J. Crisp

Partner

Martin focuses his practice on stockholder litigation, and has advised investment bank, private equity, and public company clients in connection with transactional litigations, securities actions, and derivative claims. Martin regularly represents buyers, sellers, and financial advisors in all forms of litigation arising out of corporate transactions, including breach of fiduciary duty suits and post-closing disputes. Martin has represented corporate and individual clients in all aspects of these matters at the trial and appellate levels in state and federal courts throughout the United States, as well as in non-public investigations.

Experience

  • Representing Goldman Sachs in connection with litigation arising from its role as a financial advisor in connection with multiple public company merger transactions. This includes the successful defense of claims asserted against Goldman Sachs in Kansas State Court in connection with the sale of CEC Entertainment, Inc., the parent company of Chuck E Cheese. After extensive briefing before the Kansas court and a court-appointed special master, the court dismissed the plaintiffs’ claims. The Kansas Court of Appeals affirmed that dismissal in a unanimous, 25-page decision.
  • Obtained a dismissal with prejudice for Houlihan Lokey Capital, Inc. of a class action lawsuit filed in the Delaware Court of Chancery. The suit challenged the acquisition of Synutra International, Inc. by its controlling stockholder, arguing that the Special Committee of the Synutra Board of Directors that was formed to negotiate that transaction breached its fiduciary duties and that Houlihan Lokey, which served as the Special Committee’s financial advisor, aided and abetted those breaches for a variety of reasons. No appeal was taken as to Houlihan Lokey.
  • Representing Canada Goose Holdings, Inc., its current CEO and CFO, as well as Bain Capital, in a federal securities action regarding the company’s disclosures concerning inventory and consumer demand.
  • Representing a group of investment banks, includingJ.P. Morgan,Goldman Sachs,Morgan Stanley,andChina Renaissance Securities, who underwrote the IPO of Jianpu Technology, Inc. (a China-based corporation that provides a platform for consumer lending), in a federal securities class action asserting claims under Section 11 of the Exchange Act filed in the Southern District of New York.
  • Represent many major private equity funds, including TPG and Bain Capital, as well as their portfolio companies, in a variety of matters, including transactional litigation and enforcement actions.
  • Representing multiple foreign subsidiaries of Schroders plc in litigations in federal and state courts relating to the Madoff investment fraud.
  • Representing Akcea Therapeutics and its former CEO in stockholder litigation in the Delaware Court of Chancery challenging a 2018 licensing transaction between Akcea and its controlling stockholder.
  • Representing a large manufacturer of mobile and manufactured housing in all litigation and regulatory matters arising from a merger transaction and related employee trading matters.
  • Representing Wright Medical Group N.V. in connection with litigation challenging its $5.4 acquisition by Stryker.
  • Member of deal and litigation teams that successfully represented Cubist Pharmaceuticals, Inc. in stockholder actions challenging multiple transactions, including Cubist’s $400 million acquisition of Adolor Corporation, its $800 million acquisition of Trius Therapeutics, Inc., its $800 million acquisition of Optimer Pharmaceuticals, Inc., and its $8.4 billion sale to Merck & Company. 
  • Member of deal and litigation team that successfully represented the Special Committee of the Board of Directors of Affiliated Computer Services, Inc. in defense of multiple stockholder actions in Delaware and Texas challenging the $6.4 billion acquisition of ACS by Xerox Corporation.
  • Member of deal and litigation team that successfully represented TPG Capital in the defense of multiple stockholder actions in Delaware and New York challenging TPG’s $3 billion acquisition of J.Crew.
  • Member of deal and litigation team that successfully represented TPG Capital in defense of multiple stockholder actions in Delaware and New Jersey challenging TPG’s $2 billion acquisition of Par Pharmaceutical.
  • Member of deal and litigation team that successfully represented TPG Capital in defense of multiple stockholder actions in state and federal court challenging TPG’s $5 billion acquisition of IMS Health.
  • Member of deal and litigation teams that successfully represented Bain Capital in defense of multiple stockholder actions challenging Bain’s $1.8 billion acquisition of Gymboree Corp.
  • Member of deal and litigation teams that successfully represented The Timberland Company and its directors in connection with Timberland’s $2 billion acquisition by VF Corporation.
  • Represented KIT digital, a multinational video management software and services company, in 10b-5 stock drop litigation and related derivative actions.
  • Represented a major financial institution in an SEC inquiry concerning the marketing and sale of structured financial products.
  • Represented Credit Suisse and Deutsche Bank in actions filed in Delaware, New York and Texas alleging breach of contract and business tort claims and seeking over $8 billion in damages.
  • Represented Vivendi SA in a $5 billion federal securities class action alleging that the company systematically inflated its reported earnings over a two-year period.
  • Represented Alcoa in connection with fraud and RICO claims asserted by Aluminium Bahrain concerning an alleged conspiracy to orchestrate bribes in Bahrain and overcharge for the raw materials used to make aluminum.
  • Pro Bono: Represents individual plaintiffs in suits against their traffickers in suits under federal anti-trafficking statutes, and coordinates with anti-trafficking NGOs to provide guidance on U.S. anti-trafficking law.

Publications

  • JD, cum laude, University of Pennsylvania Law School, 2004; James Wilson Scholar, Finalist in 2003-2004 Edwin R. Keedy Moot Court Competition, Lead Attorney in 2003-2004 Penn Law National Trial Team
  • BS, Cornell University, 2001
Cookie Settings